Honglin Xiang is an author at Sichuan University specializing in medicine, cell biology, and autoimmunity.
Top concepts
MedicineStrokeNeurologyImmunologyAutoimmunityCell BiologyPharmacologyImmunotherapyIschemic StrokeNeuropharmacology
Publications per year
2017–2021
2
2
Novel brain-targeting 3-n-butylphthalide prodrugs for ischemic stroke treatment
Honglin Xiang, Qiang Zhang, Yikun Han et al. · Journal of Controlled Release · 2021 · 27 citations
Rows per page
1–2 of 2